Page last updated: 2024-08-24

triazoles and bosutinib

triazoles has been researched along with bosutinib in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boysen, J; Ghosh, AK; Kay, NE; Mukhopadhyay, D; Sassoon, T; Secreto, C; Shanafelt, TD1
Bardy-Bouxin, N; Bellet, M; Chow, L; Duvillié, L; Goss, P; Láng, I; Lebrun, F; Leip, E; Moy, B; Neven, P; Sarosiek, T; Turnbull, K; Xu, B; Zacharchuk, C1

Trials

1 trial(s) available for triazoles and bosutinib

ArticleYear
Bosutinib in combination with the aromatase inhibitor letrozole: a phase II trial in postmenopausal women evaluating first-line endocrine therapy in locally advanced or metastatic hormone receptor-positive/HER2-negative breast cancer.
    The oncologist, 2014, Volume: 19, Issue:4

    Topics: Aniline Compounds; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Disease-Free Survival; Female; Humans; Letrozole; Nitriles; Postmenopause; Protein Kinase Inhibitors; Quinolines; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Triazoles

2014

Other Studies

1 other study(ies) available for triazoles and bosutinib

ArticleYear
The novel receptor tyrosine kinase Axl is constitutively active in B-cell chronic lymphocytic leukemia and acts as a docking site of nonreceptor kinases: implications for therapy.
    Blood, 2011, Feb-10, Volume: 117, Issue:6

    Topics: Aniline Compounds; Apoptosis; Axl Receptor Tyrosine Kinase; B-Lymphocytes; Benzocycloheptenes; Binding Sites; Coculture Techniques; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Myeloid Cell Leukemia Sequence 1 Protein; Nitriles; Phosphorylation; Protein Kinase Inhibitors; Protein Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Quinolines; Receptor Protein-Tyrosine Kinases; src-Family Kinases; Stromal Cells; Triazoles

2011